Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre van Damme

Showing results (1-10 of 365) with videos related to

Pageof 37
Sort By:
Vaccine|December 13, 2003
Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adultsPierre Van Damme, Margaret Burgess
Scandinavian Journal of Infectious Diseases|November 18, 2009
Age distribution of paediatric rotavirus gastroenteritis cases in Europe: the REVEAL studyCarlo Giaquinto, Pierre van Damme,
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2011
Hepatitis B and the need for a booster doseElke Leuridan, Pierre Van Damme
Expert Opinion on Drug Delivery|August 19, 2010
Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccinesVanessa Vankerckhoven, Pierre Van Damme
Journal of Medical Virology|July 13, 2002
Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001Pierre Van Damme, Alex Vorsters
Expert Review of Vaccines|August 25, 2005
Prevention of hepatitis A by Havrix: a reviewKoen Van Herck, Pierre Van Damme
The Pediatric Infectious Disease Journal|September 9, 2008
Benefits of early hepatitis B immunization programs for newborns and infantsKoen Van Herck, Pierre Van Damme
Travel Medicine and Infectious Disease|February 15, 2007
A review of the long-term protection after hepatitis A and B vaccinationPierre Van Damme, Koen Van Herck
Expert Review of Vaccines|June 5, 2004
A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccinePierre Van Damme, Koen Van Herck
Vaccine|January 9, 2007
Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006)Philippe Beutels, Nancy Thiry, Pierre Van Damme
Pageof 37

Showing results (1-10 of 365) with videos related to

Sort By:
Pageof 37
Vaccine|December 13, 2003
Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adultsPierre Van Damme, Margaret Burgess
Scandinavian Journal of Infectious Diseases|November 18, 2009
Age distribution of paediatric rotavirus gastroenteritis cases in Europe: the REVEAL studyCarlo Giaquinto, Pierre van Damme,
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2011
Hepatitis B and the need for a booster doseElke Leuridan, Pierre Van Damme
Expert Opinion on Drug Delivery|August 19, 2010
Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccinesVanessa Vankerckhoven, Pierre Van Damme
Journal of Medical Virology|July 13, 2002
Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001Pierre Van Damme, Alex Vorsters
Expert Review of Vaccines|August 25, 2005
Prevention of hepatitis A by Havrix: a reviewKoen Van Herck, Pierre Van Damme
The Pediatric Infectious Disease Journal|September 9, 2008
Benefits of early hepatitis B immunization programs for newborns and infantsKoen Van Herck, Pierre Van Damme
Travel Medicine and Infectious Disease|February 15, 2007
A review of the long-term protection after hepatitis A and B vaccinationPierre Van Damme, Koen Van Herck
Expert Review of Vaccines|June 5, 2004
A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccinePierre Van Damme, Koen Van Herck
Vaccine|January 9, 2007
Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006)Philippe Beutels, Nancy Thiry, Pierre Van Damme
Pageof 37